Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | EW | LLY |
|---|
| Close | 89.28 | 1,137.82 |
| Market Cap | $51.5B | $1.07T |
| 1M | −1.68% | −3.83% |
| P/E (TTM) | 51.2 | 39.9 |
| Forward P/E | 29.8 | 28.5 |
| P/E 5-Yr Percentile | 98 | 6 |
| P/S | 7.9 | 13.4 |
| P/B | 4.9 | 31.5 |
| Dividend Yield | — | 0.75% |
| Latest Quarter Revenue | $1.7B | $23.0B |
| Revenue YoY | +13.6% | +47.7% |
| Gross Margin | 77.5% | 85.8% |
| Latest Quarter EPS | 0.42 | 7.94 |
| Avg Post-Earnings Move | ±3.9% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.34% | 1.12% |
| 90-Day Net Insider Buying | −$4.6M | −$16.0M |
EW · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
